Features
Cinzia Builds on Its High-Fashion Women’s Collection
Thursday, April 15 2021 | 13 h 26 min | New ProductsVOILÀ New Releases
Eyewear is a part of how the world sees you. Cinzia takes that choice very seriously. Cinzia eyewear favors personal style over chasing fads, with frames designed to emanate confidence, for the woman unafraid to make her mark.
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry EyeNewsPress Release
Bausch + Lomb and Novaliq announced statistically significant topline data from the first Phase 3 trial (GOBI trial) evaluating the investigational drug NOV03 as a first-in-class eye drop.
Gene Therapy Approach to Regenerate Damaged Optic Nerves
Wednesday, April 14 2021 | 07 h 26 min | Vision Science,
Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this information could help in the development of new treatments for glaucoma.
Carl Zeiss Vision Canada and WestGroupe announce donation to Optometry Giving Sight
Tuesday, April 13 2021 | 15 h 39 min | News,
Carl Zeiss Vision Canada and WestGroupe, through their sales in ValuePak Frame and Lens packages have donated over $110,000 to Optometry Giving Sight since 2016.
WCO Passes Resolution Calling for Standard of Care for Myopia Management
Tuesday, April 13 2021 | 10 h 40 min | News, Press Release,
the World Council of Optometry (WCO) Board of Directors unanimously approved a resolution advising optometrists to incorporate a standard of care for myopia management within their practices.
Cinzia Builds on Its High-Fashion Women’s Collection
Thursday, April 15 2021 | 13 h 26 min | New ProductsVOILÀ New Releases
Eyewear is a part of how the world sees you. Cinzia takes that choice very seriously. Cinzia eyewear favors personal style over chasing fads, with frames designed to emanate confidence, for the woman unafraid to make her mark.
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry EyeNewsPress Release
Bausch + Lomb and Novaliq announced statistically significant topline data from the first Phase 3 trial (GOBI trial) evaluating the investigational drug NOV03 as a first-in-class eye drop.
Gene Therapy Approach to Regenerate Damaged Optic Nerves
Wednesday, April 14 2021 | 07 h 26 min | Vision Science,
Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this information could help in the development of new treatments for glaucoma.
Carl Zeiss Vision Canada and WestGroupe announce donation to Optometry Giving Sight
Tuesday, April 13 2021 | 15 h 39 min | News,
Carl Zeiss Vision Canada and WestGroupe, through their sales in ValuePak Frame and Lens packages have donated over $110,000 to Optometry Giving Sight since 2016.
WCO Passes Resolution Calling for Standard of Care for Myopia Management
Tuesday, April 13 2021 | 10 h 40 min | News, Press Release,
the World Council of Optometry (WCO) Board of Directors unanimously approved a resolution advising optometrists to incorporate a standard of care for myopia management within their practices.
Cinzia Builds on Its High-Fashion Women’s Collection
Thursday, April 15 2021 | 13 h 26 min | New ProductsVOILÀ New Releases
Eyewear is a part of how the world sees you. Cinzia takes that choice very seriously. Cinzia eyewear favors personal style over chasing fads, with frames designed to emanate confidence, for the woman unafraid to make her mark.
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry EyeNewsPress Release
Bausch + Lomb and Novaliq announced statistically significant topline data from the first Phase 3 trial (GOBI trial) evaluating the investigational drug NOV03 as a first-in-class eye drop.
Gene Therapy Approach to Regenerate Damaged Optic Nerves
Wednesday, April 14 2021 | 07 h 26 min | Vision Science,
Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this information could help in the development of new treatments for glaucoma.
Carl Zeiss Vision Canada and WestGroupe announce donation to Optometry Giving Sight
Tuesday, April 13 2021 | 15 h 39 min | News,
Carl Zeiss Vision Canada and WestGroupe, through their sales in ValuePak Frame and Lens packages have donated over $110,000 to Optometry Giving Sight since 2016.
WCO Passes Resolution Calling for Standard of Care for Myopia Management
Tuesday, April 13 2021 | 10 h 40 min | News, Press Release,
the World Council of Optometry (WCO) Board of Directors unanimously approved a resolution advising optometrists to incorporate a standard of care for myopia management within their practices.
Cinzia Builds on Its High-Fashion Women’s Collection
Thursday, April 15 2021 | 13 h 26 min | New ProductsVOILÀ New Releases
Eyewear is a part of how the world sees you. Cinzia takes that choice very seriously. Cinzia eyewear favors personal style over chasing fads, with frames designed to emanate confidence, for the woman unafraid to make her mark.
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry EyeNewsPress Release
Bausch + Lomb and Novaliq announced statistically significant topline data from the first Phase 3 trial (GOBI trial) evaluating the investigational drug NOV03 as a first-in-class eye drop.
Gene Therapy Approach to Regenerate Damaged Optic Nerves
Wednesday, April 14 2021 | 07 h 26 min | Vision Science,
Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this information could help in the development of new treatments for glaucoma.
Carl Zeiss Vision Canada and WestGroupe announce donation to Optometry Giving Sight
Tuesday, April 13 2021 | 15 h 39 min | News,
Carl Zeiss Vision Canada and WestGroupe, through their sales in ValuePak Frame and Lens packages have donated over $110,000 to Optometry Giving Sight since 2016.
WCO Passes Resolution Calling for Standard of Care for Myopia Management
Tuesday, April 13 2021 | 10 h 40 min | News, Press Release,
the World Council of Optometry (WCO) Board of Directors unanimously approved a resolution advising optometrists to incorporate a standard of care for myopia management within their practices.
